We Care About Patients Living with Rare and Severe Diseases
At Sobi North America, we are inspired by a single vision – to be recognized as a global leader in providing innovative medicines that transform the lives of people with rare and debilitating diseases.
Patients affected by rare diseases often face bigger challenges. That’s why we refuse to accept the status quo and are dedicated to making medicine more accessible. We are creating more possibilities for those otherwise overlooked.
We bring something unique to the fight against rare diseases – a rare strength that allows us to be a partner in care for those with high unmet needs.
We bring a personalized touch to the communities where we live and work and conduct our business with the utmost care and compassion to help ensure no patient is left behind.
Our people and their rare strength are essential to serving patients in a rapidly evolving industry. They are the change agents that continuously challenge the status quo to bring our mission to life.
Our responsibility goes beyond medicine. We believe all patients should have access to our treatments. We also meet patients where they are in their treatment journey to better address their unmet needs and improve access to care – together.
Our mission is to make a meaningful difference in the lives of thousands of the most vulnerable infants through world class research and innovative products.
Prolacta Bioscience is a privately held, life sciences company dedicated to improving the quality of life in the most fragile infants through the harmony of nature and science. We create specialty formulations made from human milk for the nutritional needs of premature infants in neonatal intensive care units (NICU). These formulations are sold to NICUs around the country.
Prolacta developed the first large scale human milk processing facility in the world. Using state-of-the-art formulation, pasteurization and filling processes, we formulate human milk to an exact standard to meet the needs of very low birth weight babies during the first 30 days of life.
Prolacta is committed to supporting research in the study of human milk and premature infant nutrition in order to make a difference in the lives of the most fragile premature babies.
You’re dedicated to caring. We’re dedicated to you.
AngelEye Health has a deep understanding of the value that both family engagement and family-centered care bring to neonatal and pediatric care environments. We provide a complete HIPAA-compliant family engagement platform to integrate parents simply and seamlessly into the child’s care team. Our approach has a proven, positive impact on the quality of the family experience, care delivery workflows for the dedicated bedside team, and patient outcomes. From admission to discharge, AngelEye Health solutions impact all stakeholders along the journey to a successful transition home. AngelEye partners with more than 200+ hospitals in the US and EU boasting a 100% retention rate since our founding in 2013.
Interested In Being a Part of Our Industry Collective?
UCommunity – UPrinting Sponsorship Program supports the NICU Parent Network